Vaccine shows therapeutic promise against advanced melanoma
Monday, June 1, 2009 - 09:56
in Health & Medicine
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.